Füsun Saygılı

1.1k total citations
65 papers, 757 citations indexed

About

Füsun Saygılı is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Füsun Saygılı has authored 65 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Füsun Saygılı's work include Pituitary Gland Disorders and Treatments (10 papers), Ovarian function and disorders (9 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Füsun Saygılı is often cited by papers focused on Pituitary Gland Disorders and Treatments (10 papers), Ovarian function and disorders (9 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). Füsun Saygılı collaborates with scholars based in Türkiye and United States. Füsun Saygılı's co-authors include Gökhan Özgen, Mehmet Erdoğan, Fulden Saraç, Canan Yılmaz, Şevki Çetinkalp, Taylan Kabalak, M. Karadeniz, Mehmet Tüzün, Sadık Tamsel and Candeğer Yılmaz and has published in prestigious journals such as Osteoporosis International, Thyroid and Cardiovascular Diabetology.

In The Last Decade

Füsun Saygılı

63 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Füsun Saygılı Türkiye 17 332 165 142 107 87 65 757
Şenay Savaş Erdeve Türkiye 17 316 1.0× 118 0.7× 218 1.5× 152 1.4× 66 0.8× 110 768
Néstor Soto Chile 12 211 0.6× 218 1.3× 82 0.6× 52 0.5× 241 2.8× 22 928
M. Thabet Canada 14 107 0.3× 143 0.9× 322 2.3× 108 1.0× 73 0.8× 40 752
Gul Bano United Kingdom 14 219 0.7× 236 1.4× 121 0.9× 166 1.6× 191 2.2× 43 773
Gürbüz Erdoğan Türkiye 15 440 1.3× 62 0.4× 78 0.5× 237 2.2× 39 0.4× 40 713
Georgios Papadakis Switzerland 15 337 1.0× 306 1.9× 220 1.5× 144 1.3× 120 1.4× 65 879
Jaak Billen Belgium 16 196 0.6× 227 1.4× 95 0.7× 85 0.8× 102 1.2× 48 934
Jean Charles Crave France 8 382 1.2× 337 2.0× 124 0.9× 33 0.3× 195 2.2× 12 811
Binghua Zhu China 15 82 0.2× 112 0.7× 165 1.2× 85 0.8× 87 1.0× 28 650
Kyong Wook Yi South Korea 18 132 0.4× 299 1.8× 56 0.4× 48 0.4× 143 1.6× 47 729

Countries citing papers authored by Füsun Saygılı

Since Specialization
Citations

This map shows the geographic impact of Füsun Saygılı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Füsun Saygılı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Füsun Saygılı more than expected).

Fields of papers citing papers by Füsun Saygılı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Füsun Saygılı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Füsun Saygılı. The network helps show where Füsun Saygılı may publish in the future.

Co-authorship network of co-authors of Füsun Saygılı

This figure shows the co-authorship network connecting the top 25 collaborators of Füsun Saygılı. A scholar is included among the top collaborators of Füsun Saygılı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Füsun Saygılı. Füsun Saygılı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gökşen, Damla, et al.. (2024). Investigation of the molecular genetic causes of non-syndromic primary ovarian ınsufficiency by next generation sequencing analysis. Archives of Endocrinology and Metabolism. 68. e220475–e220475. 2 indexed citations
2.
3.
Özdil, Berrin, Aslı Süner, Mehmet Erdoğan, et al.. (2023). The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line. Pathology - Research and Practice. 243. 154385–154385. 4 indexed citations
4.
Şimşir, İlgın Yıldırım, et al.. (2022). The prevalence and risk factors of retinopathy and nephropathy in prediabetic population. International Journal of Diabetes in Developing Countries. 43(4). 566–573. 2 indexed citations
5.
Çetinkalp, Şevki, et al.. (2022). The relationship between neutrophil lymphocyte ratio and diabetes control in patients with type 2 diabetes mellitus. Ege Tıp Dergisi. 61(3). 444–451. 2 indexed citations
6.
Şimşir, İlgın Yıldırım, Ayhan Dönmez, Ceyda Kabaroğlu, et al.. (2021). The effect of serum lipid levels on peripheral blood hematopoietic stem cell levels. Transfusion and Apheresis Science. 60(3). 103074–103074. 1 indexed citations
7.
Saygılı, Füsun, et al.. (2020). Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy. The National Medical Journal of India. 33(5). 278–278. 6 indexed citations
8.
Kutbay, Nilüfer Özdemir, et al.. (2019). Plasma Levels of Antioxidant Vitamins in Patients with Acromegaly: A Case-Control Study.. PubMed. 40(7-8). 308–314. 1 indexed citations
9.
Şimşir, İlgın Yıldırım, Banu Şarer Yürekli, Mehmet Erdoğan, et al.. (2019). Therapeutic plasma exchange in hypertriglyceridemic patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(3). 872–878. 6 indexed citations
10.
Yürekli, Banu Şarer, Burçak Karaca, Aslı Kısım, et al.. (2017). AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells. Journal of Endocrinological Investigation. 41(2). 233–240. 6 indexed citations
11.
Vardarli, Aslı Teti̇k, Vildan Bozok Çetintaş, Muammer Karadeniz, et al.. (2015). An Association Study Between Gene Polymorphisms of Folic Acid Metabolism Enzymes and Biochemical and Hormonal Parameters in Acromegaly. Genetic Testing and Molecular Biomarkers. 19(8). 431–438. 4 indexed citations
12.
Karadeniz, Muammer, Vildan Bozok Çetintaş, Aslı Teti̇k Vardarli, et al.. (2013). Is There Any Association Between the Ser326Cys Polymorphism of the 8-Oxoguanine Glycosylase 1 ( OGG1 ) Gene and Risk of Colon Polyp and Abnormal Glucose Tolerance in Acromegaly Patients?. Genetic Testing and Molecular Biomarkers. 17(4). 267–273. 2 indexed citations
13.
Erdoğan, Mehmet, Şevki Çetinkalp, Gökhan Özgen, et al.. (2011). Interleukin-10 (-1082G/A) Gene Polymorphism in Patients With Type 2 Diabetes With and Without Nephropathy. Genetic Testing and Molecular Biomarkers. 16(2). 91–94. 28 indexed citations
14.
Çetintaş, Vildan Bozok, Aslı Teti̇k Vardarli, Muammer Karadeniz, et al.. (2011). Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly?. Endocrine. 41(3). 465–472. 4 indexed citations
15.
Karadeniz, Muammer, Mehmet Erdoğan, Murat Yalçın, et al.. (2011). Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome. Lipids in Health and Disease. 10(1). 193–193. 15 indexed citations
16.
Saraç, Fulden, et al.. (2008). Prolactin levels and examination with breast ultrasound or mammography. Advances in Therapy. 25(1). 59–66. 5 indexed citations
17.
Saraç, Fulden, Güray Saydam, Fahri Şahin, et al.. (2008). Effects of Hormone Replacement Therapy on Insulin Resistance and Platelet Function Tests. Medical Principles and Practice. 18(1). 43–47. 7 indexed citations
18.
Erdoğan, Murat Faik, Afig Berdeli, M. Karadeniz, et al.. (2008). The Prevalence of RET/PTC Mutations in Papillary Thyroid Cancers in Turkish Population and its Relation Between Tumor Histopathology and Prognostic Factors. Experimental and Clinical Endocrinology & Diabetes. 116(4). 225–230. 6 indexed citations
19.
Saraç, Fulden, Füsun Saygılı, Gökhan Özgen, et al.. (2006). Assessment of Insulin Resistance in the Idiopathic Hirsutism. Gynecologic and Obstetric Investigation. 63(3). 126–131. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şenay Savaş Erdeve Breakdown of academic impact, for papers by Néstor Soto Breakdown of academic impact, for papers by M. Thabet Breakdown of academic impact, for papers by Gul Bano Breakdown of academic impact, for papers by Gürbüz Erdoğan Breakdown of academic impact, for papers by Georgios Papadakis Breakdown of academic impact, for papers by Jaak Billen Breakdown of academic impact, for papers by Jean Charles Crave Breakdown of academic impact, for papers by Binghua Zhu Breakdown of academic impact, for papers by Kyong Wook Yi
Rankless by CCL
2026